Company Analysis Viela Bio, Inc.
1. Summary
Advantages
- The stock's return over the last year (99.66%) is higher than the sector average (15.6%).
- The company's current efficiency (ROE=-41.26%) is higher than the sector average (ROE=-80.89%)
Disadvantages
- Price (53.01 $) is higher than fair price (29.11 $)
- Dividends (0%) are below the sector average (1.22%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
Viela Bio, Inc. | Healthcare | Index | |
---|---|---|---|
7 days | 99.7% | -28.7% | 4% |
90 days | 99.7% | -0% | 12% |
1 year | 99.7% | 15.6% | 36.3% |
VIE vs Sector: Viela Bio, Inc. has outperformed the "Healthcare" sector by 84.06% over the past year.
VIE vs Market: Viela Bio, Inc. has outperformed the market by 63.33% over the past year.
Slightly volatile price: VIE is more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical deviations of about +/- 5-15% per week.
Long period: VIE with weekly volatility of 1.92% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (53.01 $) is higher than the fair price (29.11 $).
Price is higher than fair: The current price (53.01 $) is 45.1% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (58.16).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (47.31).
4.3. P/BV
P/BV vs Sector: The company's P/BV (4.87) is lower than that of the sector as a whole (9.41).
P/BV vs Market: The company's P/BV (4.87) is lower than that of the market as a whole (22.52).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (249.99) is higher than that of the sector as a whole (4.08).
P/S vs Market: The company's P/S indicator (249.99) is higher than that of the market as a whole (15.08).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-16.72) is lower than that of the sector as a whole (17.46).
EV/Ebitda vs Market: The company's EV/Ebitda (-16.72) is lower than that of the market as a whole (22.73).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 14.88% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (14.88%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-14.29%).
5.4. ROE
ROE vs Sector: The company's ROE (-41.26%) is higher than that of the sector as a whole (-80.89%).
ROE vs Market: The company's ROE (-41.26%) is lower than that of the market as a whole (17.15%).
5.5. ROA
ROA vs Sector: The company's ROA (-23.83%) is lower than that of the sector as a whole (6.64%).
ROA vs Market: The company's ROA (-23.83%) is lower than that of the market as a whole (6.59%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.22%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription